pharma · Influenza immunisation
Abott Laboratories
Abbott Laboratories
Abbott Laboratories is a pharma organization headquartered in Moscow, RU. Primary therapeutic focus areas include Influenza immunisation. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record
Moscow, RU HQ
576 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Moscow, RU
- Employees
- 576
- Programs
- 1
- Drugs
- 4
- Patents
- 25
INFQ-324-0476
Phase 3 · small molecule · Influenza immunisation
INFQ-324-0476 for Influenza immunisation is a Phase 3 program (small_molecule) at Abbott Laboratories with 1 ClinicalTrials.gov record(s).
Internal code INFQ-324-0476
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Abbott Laboratories
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Influenza immunisation
- Status
- active
- Trials
- 1